Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Davunetide for Progressive Supranuclear Palsy (Phase 2/3 Randomized Double-Blind Placebo-Controlled)
2010-019159-23Phase 2Completed
- Sponsor
- Allon Therapeutics Inc
- Start
- Aug 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of davunetide in progressive supranuclear palsy (PSP), sponsored by Allon Therapeutics Inc. Started Aug 2010; status: completed.
02
Drugs
davunetide
03
Conditions
progressive supranuclear palsy (PSP)
Beyond the preview
Go deeper on 2010-019159-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019159-23.